![Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension | Arteriosclerosis, Thrombosis, and Vascular Biology Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/9321b2aa-a6c2-464f-8783-d5da1022514e/145ga1.jpg)
Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension | Arteriosclerosis, Thrombosis, and Vascular Biology
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell | Journal of the American Chemical Society
GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats | ACS Pharmacology & Translational Science
![Frontiers | Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis Frontiers | Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis](https://www.frontiersin.org/files/Articles/846903/fendo-13-846903-HTML/image_m/fendo-13-846903-g001.jpg)
Frontiers | Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
![Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs43440-021-00274-8/MediaObjects/43440_2021_274_Figa_HTML.png)
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports
![Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes - ScienceDirect Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S266637912200115X-fx1.jpg)
Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes - ScienceDirect
![GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last? - The Lancet Diabetes & Endocrinology GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last? - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/09e23802-5dfe-4401-81fa-49f0e4ac821f/gr1_lrg.jpg)
GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last? - The Lancet Diabetes & Endocrinology
![Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology - Osmosis Video Library Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology - Osmosis Video Library](https://osmose-it.s3.amazonaws.com/2NFuekpeTkaJQt-dnltFcOyaQFu48o2o/_.jpg)
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology - Osmosis Video Library
![Glucagon Like Peptide 1 (GLP-1) Agonist Drugs for Type 2 Diabetes | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives Glucagon Like Peptide 1 (GLP-1) Agonist Drugs for Type 2 Diabetes | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives](https://en.huatengsci.com/usr/uploads/3/202008/F1large.jpg)
Glucagon Like Peptide 1 (GLP-1) Agonist Drugs for Type 2 Diabetes | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives
Global Glucagon-like Peptide 1 (GLP-1) Market Analysis Report 2023: Potential Clinical Application of GLP-1 Receptor Agonists For the Treatment of NASH Gaining Momentum
![What are the gastrointestinal adverse effects of the glucagon-like peptide 1 receptor agonists, and how should they be managed? | Illinois ADVANCE What are the gastrointestinal adverse effects of the glucagon-like peptide 1 receptor agonists, and how should they be managed? | Illinois ADVANCE](https://illinoisadvance.com/media/images/GLP-1_RA_1.31.22_2.original.png)
What are the gastrointestinal adverse effects of the glucagon-like peptide 1 receptor agonists, and how should they be managed? | Illinois ADVANCE
![Cells | Free Full-Text | GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight Cells | Free Full-Text | GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight](https://www.mdpi.com/cells/cells-11-02023/article_deploy/html/images/cells-11-02023-g001.png)